• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

When antibiotic treatment fails.

作者信息

Bassetti Matteo, Montero Josè Garnacho, Paiva José Artur

机构信息

Infectious Diseases Clinic, Department of Medicine, University of Udine and Azienda Sanitaria Universitaria Integrata, Udine, Italy.

Clinica Malattie Infettive, Azienda Sanitaria Universitaria Integrata, Presidio Ospedaliero Universitario Santa Maria della Misericordia, Piazzale Santa Maria della, Misericordia 15, 33100, Udine, Italy.

出版信息

Intensive Care Med. 2018 Jan;44(1):73-75. doi: 10.1007/s00134-017-4962-2. Epub 2017 Oct 14.

DOI:10.1007/s00134-017-4962-2
PMID:29032500
Abstract
摘要

相似文献

1
When antibiotic treatment fails.当抗生素治疗失败时。
Intensive Care Med. 2018 Jan;44(1):73-75. doi: 10.1007/s00134-017-4962-2. Epub 2017 Oct 14.
2
Clinical approach to antibiotic failure.
Med Clin North Am. 2006 Nov;90(6):1265-77. doi: 10.1016/j.mcna.2006.07.004.
3
Emergence of antibiotic resistance: need for a new paradigm.抗生素耐药性的出现：需要一种新的范式。
Clin Microbiol Infect. 2012 Jul;18(7):615-6. doi: 10.1111/j.1469-0691.2012.03902.x.
4
[Refractory borreliosis--failed antibiotic treatment--what now? Reconsider the diagnosis!].[难治性莱姆病——抗生素治疗失败——现在怎么办？重新考虑诊断！]
MMW Fortschr Med. 2003 Nov 20;145(47):13.
5
Antibiotic treatment of diseases without an evident infectious etiology.
Infection. 2006 Dec;34(6):299. doi: 10.1007/s15010-006-7606-y.
6
Antibiotic stewardship: a call for action by the urologic community.抗生素管理：泌尿科领域的行动呼吁。
Eur Urol. 2013 Sep;64(3):358-60. doi: 10.1016/j.eururo.2013.05.044. Epub 2013 May 29.
7
[Initial empirical antibiotic treatment of community-acquired pneumonia in immunocompetent adult patients].
Rev Esp Quimioter. 2003 Dec;16(4):457-66.
8
[Factors predicting failure in empirical antibiotic treatment].[经验性抗生素治疗失败的预测因素]
An Sist Sanit Navar. 2017 Apr 30;40(1):119-130. doi: 10.23938/ASSN.0011.
9
[Community acquired pneumonia: how to proceed when the antibiotic does not help?].[社区获得性肺炎：抗生素治疗无效时如何应对？]
MMW Fortschr Med. 2011 Sep 22;153(38):12, 14.
10
Impact of antibiotic restrictions: the ethical perspective.抗生素限制的影响：伦理视角
Clin Microbiol Infect. 2006 Aug;12 Suppl 5:16-24. doi: 10.1111/j.1469-0691.2006.01527.x.

引用本文的文献

1
How to approach a patient hospitalized for pneumonia who is not responding to treatment?对于因肺炎住院但治疗无反应的患者，应如何处理？
Intensive Care Med. 2025 May 24. doi: 10.1007/s00134-025-07903-3.
2
Accessing the behavior and awareness of veterinary professionals towards antimicrobials use and antimicrobial resistance in Indian district.了解印度某地区兽医专业人员对抗菌药物使用及抗菌药物耐药性的行为和认知。
Front Vet Sci. 2024 Mar 11;11:1342089. doi: 10.3389/fvets.2024.1342089. eCollection 2024.
3
Novel Antibacterial Agents SAAP-148 and Halicin Combat Gram-Negative Bacteria Colonizing Catheters.

本文引用的文献

1
Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach.未来 30 年的抗菌药物耐药性：人类、细菌和药物——有远见的方法。
Intensive Care Med. 2017 Oct;43(10):1464-1475. doi: 10.1007/s00134-017-4878-x. Epub 2017 Jul 21.
2
Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net.评估严重感染新型抗生素疗法的合适终点：来自COMBACTE的STAT-Net的观点
Intensive Care Med. 2017 Jul;43(7):1002-1012. doi: 10.1007/s00134-017-4802-4. Epub 2017 May 2.
3
Community-acquired pneumonia: identification and evaluation of nonresponders.
新型抗菌剂SAAP-148和Halicin对抗定殖于导管的革兰氏阴性菌。
Antibiotics (Basel). 2023 Dec 16;12(12):1743. doi: 10.3390/antibiotics12121743.
4
Antibiotic prescribing behavior among physicians in Asia: a multinational survey.亚洲医生的抗生素处方行为：一项跨国调查。
Antimicrob Steward Healthc Epidemiol. 2023 Jun 29;3(1):e112. doi: 10.1017/ash.2023.190. eCollection 2023.
5
Essential components of a definition for early antibiotic treatment failure: A scoping review.早期抗生素治疗失败定义的基本要素：范围综述。
PLoS One. 2023 Jun 23;18(6):e0283417. doi: 10.1371/journal.pone.0283417. eCollection 2023.
6
Outcomes in participants with failure of initial antibacterial therapy for hospital-acquired/ventilator-associated bacterial pneumonia prior to enrollment in the randomized, controlled phase 3 ASPECT-NP trial of ceftolozane/tazobactam versus meropenem.在随机、对照的 3 期 ASPECT-NP 试验中，在纳入头孢他洛滨/他唑巴坦与美罗培南比较的随机、对照 3 期 ASPECT-NP 试验之前，对于初始抗菌治疗失败的医院获得性/呼吸机相关性细菌性肺炎参与者的结局。
Crit Care. 2022 Dec 1;26(1):373. doi: 10.1186/s13054-022-04192-w.
7
Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Infections in Patients With Liver Cirrhosis.头孢他啶-阿维巴坦用于治疗肝硬化患者的碳青霉烯类耐药感染
J Clin Exp Hepatol. 2022 Sep-Oct;12(5):1293-1300. doi: 10.1016/j.jceh.2022.04.016. Epub 2022 Apr 21.
8
Variation in Antibiotic Treatment Failure Outcome Definitions in Randomised Trials and Observational Studies of Antibiotic Prescribing Strategies: A Systematic Review and Narrative Synthesis.抗生素处方策略随机试验和观察性研究中抗生素治疗失败结局定义的差异：一项系统评价与叙述性综合分析
Antibiotics (Basel). 2022 May 6;11(5):627. doi: 10.3390/antibiotics11050627.
9
A Review: Antimicrobial Therapy for Human Pythiosis.综述：人类腐皮病的抗菌治疗
Antibiotics (Basel). 2022 Mar 26;11(4):450. doi: 10.3390/antibiotics11040450.
10
Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System.头孢洛林酯用于经验性治疗住院成年社区获得性皮肤及软组织感染患者：基于西班牙国家卫生系统视角的经济学分析
Clinicoecon Outcomes Res. 2022 Mar 18;14:149-161. doi: 10.2147/CEOR.S329494. eCollection 2022.
社区获得性肺炎：无反应者的识别与评估
Ther Adv Infect Dis. 2013 Feb;1(1):5-17. doi: 10.1177/2049936112469017.
4
De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock.经验性治疗降级与严重脓毒症和感染性休克患者的死亡率降低相关。
Intensive Care Med. 2014 Jan;40(1):32-40. doi: 10.1007/s00134-013-3077-7. Epub 2013 Sep 12.
5
Progress on developing endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: update from the Biomarkers Consortium of the Foundation for the National Institutes of Health.开发社区获得性细菌性肺炎和急性细菌性皮肤和皮肤结构感染注册临床试验终点的进展：来自美国国立卫生研究院基金会生物标志物联盟的最新消息。
Clin Infect Dis. 2012 Oct;55(8):1114-21. doi: 10.1093/cid/cis566. Epub 2012 Jun 28.
6
Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial.降钙素原指导抗感染治疗以增加早期适当使用抗生素并改善重症监护病房患者的生存率：一项随机试验。
Crit Care Med. 2011 Sep;39(9):2048-58. doi: 10.1097/CCM.0b013e31821e8791.
7
Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia.降级治疗对 ICU 获得性肺炎临床结局的影响。
Crit Care. 2011;15(2):R79. doi: 10.1186/cc10072. Epub 2011 Mar 2.
8
Early antibiotic treatment failure.
Int J Antimicrob Agents. 2009 Aug;34 Suppl 3:S14-9. doi: 10.1016/S0924-8579(09)70552-7.
9
Markers of treatment failure in hospitalised community acquired pneumonia.住院社区获得性肺炎治疗失败的标志物
Thorax. 2008 May;63(5):447-52. doi: 10.1136/thx.2007.086785. Epub 2008 Feb 1.
10
Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia.降钙素原和C反应蛋白水平降低是呼吸机相关性肺炎患者生存的有力预测指标。
Crit Care. 2006;10(5):R125. doi: 10.1186/cc5036.